Skip to main content
Fig. 1 | BMC Cancer

Fig. 1

From: GDF15 predict platinum response during first-line chemotherapy and can act as a complementary diagnostic serum biomarker with CA125 in epithelial ovarian cancer

Fig. 1

The level of serum GDF15 and CA125 in patients with EOC and healthy control. Serum GDF15 and CA125 in patients with EOC is significantly higher than that of others (P < 0.0001), notably, an elevated level of GDF15 was significantly presented in the stage I-II. Moreover, the gradual elevation in serum GDF15 and CA125 was clearly discernible, with significantly higher serum level in stage III -IV. Ovarian carcinoma refers to the group of all patients with ovarian cancer, Stage I-IV refers to the stage I to IV of ovarian cancer patients individually

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us